Search
Wednesday 19 August 2015
  • :
  • :

Current Trade Stocks Roundup: DryShips (NASDAQ:DRYS), Sequenom, (NASDAQ:SQNM), Amira Nature Foods (NYSE:ANFI), Magellan Midstream Partners, L.P.(NYSE:MMP)

During Monday’s Current trade, Shares of DryShips Inc. (NASDAQ:DRYS), gain 1.00% to $0.375.

DryShips Inc. (NASDAQ: DRYS), or DryShips or the Company, an international provider of marine transportation services for drybulk and petroleum cargoes, and through its associate, Ocean Rig UDW Inc., or Ocean Rig, of offshore deepwater drilling services, recently declared its unaudited financial and operating results for the second quarter ended June 30, 2015.

Second Quarter 2015 Financial Highlights

  • For the second quarter of 2015, the Company stated a net loss of $1.44 billion, or $2.17 basic and diluted loss per share.

    Comprised of in the second quarter 2015 results are:

    • A one-time non-cash loss of $1.35 billion, or $2.03 per share, as a result of the deconsolidation of Ocean Rig.
    • Impairment charge on one drybulk vessel, of $83.9 million, or $0.13 per share.

DryShips Inc. provides ocean transportation services for drybulk and petroleum cargoes, and offshore deepwater drilling services. The company operates through Drybulk, Tanker, and Drilling segments. The Drybulk segment provides drybulk commodities transportation services for the steel, electric utility, construction, and agri-food industries. The Drilling segment offers ultra deep water drilling services.

Shares of Sequenom, Inc. (NASDAQ:SQNM), inclined 1.76% to $2.32, during its current trading session.

Sequenom, Inc. (SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, stated total revenues of $32.8 million for the second quarter of 2015, a decrease of 18% contrast to revenues of $39.8 million for the second quarter of 2014. Revenues for the second quarter of 2014 comprised of about $6.1 million of incremental “catch-up” payments from payors for services performed in preceding periods, in addition to the incremental change for the conversion from cash to accrual accounting for certain payors. No noteworthy catch-up collections were received in the second quarter of 2015, as the timeliness of collections has improved with additional payor contracts. Sequenom now has coverage for 172 million commercial lives and 40 million lives under Medicaid programs. The second quarter of 2015 had lower diagnostic services revenues contrast to the second quarter of 2014 by about $3 million, associated with the conversion of a referring laboratory partner to a patent pool licensee.

License revenues raised to $1.9 million for the second quarter of 2015, contrast to $0.4 million for the second quarter of 2014, reflecting the enhance in test fees under the Pooled Patents Agreement that was signed in December 2014.

Cash burn for the second quarter of 2015 was $2.9 million, contrast to $4.1 million in the same period of 2014. The second quarter 2015 cash burn excludes payment of costs related to the convertible debt exchange of $1.6 million. The loss from ongoing operations before income taxes reduced by 41% to $9.0 million for the second quarter of 2015 as contrast to $15.3 million for the second quarter of 2014.

Sequenom, Inc., a life sciences company, develops and commercializes molecular diagnostics testing services for the women’s health and oncology markets in the United States and internationally. The company provides molecular based laboratory developed tests (LDTs) comprising MaterniT21 PLUS LDT, a noninvasive prenatal test (NIPT) to detect fetal chromosomal abnormalities; HerediT CF LDT, a carrier screen test to identify individuals with cystic fibrosis or genetic mutations; SensiGene fetal Rhesus D (RhD) LDT, a NIPT to determine the presence or absence of RhD factor by direct detection of the fetal RhD genotype in RhD negative mothers from a maternal blood sample; and VisibiliT LDT, a NIPT to detect fetal chromosomal abnormalities by determining the relative amount of chromosomal material present in circulating cell-free DNA in a maternal blood sample.

Amira Nature Foods Ltd (NYSE:ANFI), during its Monday’s current trading session decreased -2.56% to $7.60.

Amira Nature Foods Ltd (ANFI), a leading global provider of branded, packaged Indian specialty rice, recently stated financial results for its fiscal 2015 full year and fourth quarter ended on March 31, 2015.

FY 2015 Financial Highlights as compared to FY 2014:

  • Revenue grew 27.8% to $699.4 million contrast to $547.3 million.
  • Adjusted EBITDA raised 31.9% to $99.5 million contrast to $75.5 million.
  • Adjusted EBITDA margin of 14.2%.
  • Adjusted profits after tax was $54.3 million contrast to $41.0 million.
  • Adjusted earnings per share (“EPS”) was $1.51 contrast to $1.14.

Fourth Quarter 2015 Financial Highlights as compared to Fourth Quarter 2014:

  • Revenue grew 21.6% to $226.8 million contrast to $186.6 million.
  • Adjusted EBITDA raised 25.1% to $33.0 million contrast to $26.4 million.
  • Adjusted EBITDA margin of 14.5%.
  • Adjusted profits after tax was $18.6 million contrast to $16.8 million.

Amira Nature Foods Ltd is engaged in processing, distributing, and marketing packaged specialty rice and other food products. The company provides various types of basmati rice, specialty rice and value add meals, ready-to-eat snacks, ready to heat means, edible oils, organics, and dairy products for retailers under the Amira brand; and non-basmati rice. It also sells bulk commodities, counting wheat, barley, legume, maize, sugar, soybean meal, onion, potatos, and millets to trading firms. Amira Nature Foods Ltd sells its products to distributors and retail chains in India; and buyers in the Asia Pacific, the Middle East, Europe, North Africa, and North America.

Finally, Magellan Midstream Partners, L.P. (NYSE:MMP), gained 1.08%, to $70.98.

Magellan Midstream Partners, L.P. (MMP) stated net income of $177.4 million for second quarter 2015, an enhance of $31.1 million, or 21% higher than the $146.3 million generated in second quarter 2014.

Distributable cash flow (DCF), a non-generally accepted accounting principles (non-GAAP) financial measure that represents the amount of cash generated during the period that is accessible to pay distributions, was $222.8 million for second quarter 2015 contrast to $195.8 million for second quarter 2014, representing a 14% enhance.

Diluted net income per limited partner unit was 78 cents in second quarter 2015 and 64 cents in second quarter 2014. Diluted net income per unit not taking into account mark-to-market (MTM) commodity-related pricing adjustments, a non-GAAP financial measure, of 82 cents for second quarter 2015 was higher than the 75-cent guidance offered by administration in May 2015 primarily due to higher shipments on the BridgeTex pipeline and higher-than-predictable commodity prices during the quarter.

Magellan Midstream Partners, L.P. engages in the transportation, storage, and distribution of refined petroleum products and crude oil in the United States. It operates in three segments: Refined Products, Crude Oil, and Marine Storage. The company operates refined products pipeline that transports gasoline, distillates, aviation fuels, and liquefied petroleum gases for independent and integrated oil companies, wholesalers, retailers, traders, railroads, airlines, and regional farm cooperatives; leases pipeline and storage tank capacity to shippers; and provides services, counting terminalling, ethanol and biodiesel loading and unloading, additive injection, custom blending, laboratory testing, and data services.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *